{
    "organizations": [],
    "uuid": "c0f1127f3d48b54b34633a05df847535f83d031d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biofrontera-resolves-on-capital-in/brief-biofrontera-resolves-on-capital-increase-idUSFWN1PO10O",
    "ord_in_thread": 0,
    "title": "BRIEF-Biofrontera Resolves On Capital Increase",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 29 (Reuters) - BIOFRONTERA AG:\n* PTA-ADHOC: BIOFRONTERA AG: BIOFRONTERA AG RESOLVES ON CAPITAL INCREASE\n* ‍TO INCREASE COMPANY‘S SHARE CAPITAL AGAINST CASH CONTRIBUTIONS BY ISSUING UP TO 6 MILLION NEW SHARES​\n* SUBSCRIPTION PRICE SHALL BE FIXED AND PUBLISHED NO LATER THAN 09 FEBRUARY 2018\n* ‍STATUTORY SUBSCRIPTION RIGHT IS GRANTED TO SHAREHOLDERS IN A 13:2 RATIO​\n* ‍NEW SHARES SHALL SERVE AS A BASIS FOR CREATION OF ADSS TO BE OFFERED IN USA​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-29T22:33:00.000+02:00",
    "crawled": "2018-01-30T18:55:19.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "biofrontera",
        "ag",
        "biofrontera",
        "ag",
        "biofrontera",
        "ag",
        "resolve",
        "capital",
        "increase",
        "increase",
        "company",
        "share",
        "capital",
        "cash",
        "contribution",
        "issuing",
        "million",
        "new",
        "subscription",
        "price",
        "shall",
        "fixed",
        "published",
        "later",
        "february",
        "subscription",
        "right",
        "granted",
        "shareholder",
        "share",
        "shall",
        "serve",
        "basis",
        "creation",
        "adss",
        "offered",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}